Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant
- 1 January 2003
- journal article
- case report
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 4 (1) , 49-51
- https://doi.org/10.1097/00130478-200301000-00009
Abstract
The authors present the use of synthetic factor VIIa to treat bleeding after cardiopulmonary bypass and surgical repair of an atrial septal defect in an infant with trisomy 10 and pulmonary hypertension. Case report. University-affiliated pediatric intensive care unit. A 4-mo-old, 3.7-kg infant. After a single dose of synthetic factor VIIa, there was normalization of the prothrombin and partial thromboplastin time and cessation of bleeding. The potential benefits of synthetic factor VIIa when compared with conventional therapy with fresh frozen plasma are discussed. Previous experience with synthetic factor VIIa in pediatric-aged patients and the cardiothoracic surgical population is presented.Keywords
This publication has 11 references indexed in Scilit:
- Synthetic Factor VIIa to Treat Dilutional Coagulopathy during Posterior Spinal Fusion in Two ChildrenAnesthesiology, 2002
- Pharmacologic preservation of the hemostatic system during cardiac surgeryThe Annals of Thoracic Surgery, 2001
- Combined Fresh Frozen Plasma with Recombinant Factor VIIa in Restoring Hemostasis for Invasive Procedures in Children with Liver DiseasesThrombosis and Haemostasis, 2001
- Recombinant Coagulation Factor VIIa: From the Concept to Clinical Application in Hemophilia Treatment in 2000Seminars in Thrombosis and Hemostasis, 2000
- Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulationBlood Coagulation & Fibrinolysis, 2000
- Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgeryBlood Coagulation & Fibrinolysis, 2000
- Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor VIITransplantation Proceedings, 1999
- SUCCESSFUL USE OF RECOMBINANT FACTOR VIIa IN PATIENT WITH SEVERE HAEMOPHILIA A DURING SYNOVECTOMYThe Lancet, 1988
- EFFECfS OF DIAZEPAM AND FLUHAZENIL ON SEDATION AND HYPOXIC VENTILATORY RESPONSEAnesthesia & Analgesia, 1988
- Noncardiogenic pulmonary edema after cardiopulmonary bypassThe American Journal of Surgery, 1984